Deployment of Transchromosomal Bovine for Personalized Antimicrobial Therapy

Authors:

Abstract
For decades, intravenous immunoglobulin (IVIg) has provided safe and effective therapy for immunodeficient patients. This proof-of-principle study describes a novel approach to generate personalized IVIg for chronic, antibiotic-resistant infection in real time.
Funding Information
  • Brigham and Women’s Hospital

This publication has 10 references indexed in Scilit: